Skip to main content
Clinical Trials/NCT06937606
NCT06937606Enrolling By InvitationNot Applicable

A Randomized, Controlled Trial to Increase Self-compassion and Decrease Caregiving Fatigue in Group Leaders of a Support Group for Women After Cancer (GLOW) - an Adaption of the Mindful Self-Compassion Program for Healthcare Communities

Wuerzburg University Hospital1 site in 1 country64 target enrollmentStarted: July 31, 2024Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Enrolling By Invitation
Enrollment
64
Locations
1
Primary Endpoint
self-compassion as assessed by Self-compassion scale in german version (SCS-D)

Study Overview

Brief Summary

This exploratory study aims to evaluate the effect of a self-compassion training developed for health professionals on leaders of self-help groups.

Hypothesis/primary goal: An online group intervention adapted from the "Self-compassion for health-care communities program" validated for health professionals leads to an increase in self-compassion among leaders of cancer self-help groups. Secondary goals: level of self-compassion at the end of the course as a mediator for therapeutic variables after 6 weeks, decrease in caregiver fatigue, secondary traumatic stress/burnout risk, personal distress and sick leave, decrease in fears of self-compassion/compassion for others; increase in mindfulness, self-efficacy, compassion for others and resilience; direct costs; safety;

Intervention:

Online group intervention: led by a certified mindfulness teacher for Mindful Self-Compassion and additional qualification in Self-Compassion in Healthcare Communities (duration: 6 weekly appointments of 90 min each); control intervention: waiting group

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Group leaders of a self-help group for cancer patients
  • •written informed consent

Exclusion Criteria

  • •Medical or mental condition that, in the opinion of the investigator, does not allow the participant to take part in the study or to provide a legally valid signature of the informed consent (e.g. insufficiently controlled pre-existing mental illness or post-traumatic stress disorder)
  • •Lack of willingness to store and share personal health data as part of the protocol
  • •Participation in another mindfulness study
  • •Lack of knowledge of German

Arms & Interventions

Self-compassion training

Experimental

Online group intervention: led by a certified mindfulness teacher for mindful self-compassion and additional qualification in self-compassion in healthcare communities (duration: 6 weekly appointments of 90 min each);

Intervention: Self-compassion training (Behavioral)

waiting list control

No Intervention

waiting list control

Outcomes

Primary Outcomes

self-compassion as assessed by Self-compassion scale in german version (SCS-D)

Time Frame: 6 weeks after baseline

Determining self-compassion after the intervention by means of a confirmatory test for group differences in the primary endpoint according to the ITT principle using a linear regression model; instrument: SCS-D

Secondary Outcomes

  • secondary traumatic stress/burnout risk as assesd by ProQoL(12 weeks after baseline)
  • Decrease in compassion fatigue as assessed by ProQoL(12 weeks after baseline)
  • personal distress (PSS-10)(12 weeks after baseline)
  • increase in resilience (BRS)(12 weeks after baseline)
  • Number of participants with treatment-related adverse events as assessed by CTCAE v4.0(12 weeks after baseline)
  • decrease in fears of self-compassion (FCS)(12 weeks after baseline)
  • compassion for others (COS-7)(12 weeks after baseline)
  • increase in mindfulness (FFMQ)(12 weeks after baseline)
  • increase in self-efficacy (SWE)(12 weeks after baseline)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Dr. Claudia Loeffler

PD Dr. med., Senior physician

Wuerzburg University Hospital

Study Sites (1)

Loading locations...

Similar Trials